Project Grant R01DK146365
- Federal Grant Award Summary The Washington University received a $1,491,303 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 5, 2025, through September 4, 2029. This award funds basic biomedical research aimed at improving understanding of the molecular mechanisms underlying the progression from acute kidney injury (AKI) to chronic...
- Federal Grant Award Summary The University of Missouri System received a Project Grant award of $709,369 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective February 1, 2026, with completion targeted for November 30, 2030. This research initiative investigates the role of the FOXL2 gene during urethra closure to address hypospadias, one of the most common birth...
- Federal Project Grant Award Summary The University of Michigan received a $690,854 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded on February 1, 2026, with a completion date of December 31, 2030. The research project, titled "Mechanisms of Epithelial Cell State Changes During Kidney Injury," investigates molecular and genetic...
- Federal Project Grant Award Summary The University of Kansas Medical Center Research Institute, Inc. received a $166,740 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective August 1, 2025, through July 31, 2030. This award funds research investigating the contribution of urinary phosphate to chronic kidney disease (CKD) progression, a condition...
- Federal Grant Award Summary Augusta University Research Institute, Inc. received a $596,345 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded May 1, 2025, with completion targeted for March 31, 2029. The grant supports biomedical research investigating the molecular mechanisms underlying diabetic renal hypertrophy and its impact on acute kidney...
- Federal Project Grant Award Summary The University of Miami's Office of Research Administration – School of Medicine received a $715,188 project grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded February 15, 2026, with a completion date of December 31, 2029. This research initiative focuses on investigating the critical role of endothelial inflammation in...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the University of Virginia $162,476 on June 3, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct research on renin cell identity and function. The project, titled "The Reninness Score: Integrative Analysis of Multi-Omic Data to Define Renin Cell Identity," will be completed by December 31, 2026. The research...
- Federal Project Grant Award Summary The University of Chicago received a $151,040 project grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded on December 11, 2025, with a completion date of November 30, 2028. This research project establishes the zebrafish pronephros (embryonic kidney) as an in vivo model system to investigate how epithelial cell collectives...
- Federal Grant Award Summary Murray State University received a $116,376 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 15, 2025, with a completion date of May 31, 2029. The grant funds basic biomedical research aimed at elucidating the mechanisms by which the transcription factor GLI-Similar 3 (GLIS3) regulates embryological...
- Federal Project Grant Award Summary The University of Texas Southwestern Medical Center received a $336,272 project grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective May 1, 2025 through January 31, 2030. This five-year research initiative will investigate the role of nicotinamide adenine dinucleotide (NAD+) and poly(ADP-ribose) polymerase 1...
The University of Missouri System received a $588,892 project grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded February 5, 2026, with completion targeted for November 30, 2029. This research initiative, conducted in Columbia, Missouri, focuses on elucidating the regulation and pathophysiological role of voltage-gated sodium (Nav) channels in renal vascular smooth muscle cells and their contribution to hypoperfusion in neonatal ischemic acute kidney injury. The project delivers fundamental biomedical research aimed at improving understanding of disease mechanisms underlying kidney dysfunction in neonates. Specifically, the research examines Nav1.5 channel function in the renal preglomerular microvasculature, the spatial relationship between Nav channels and sodium-calcium exchangers, and the signaling pathways through which nitric oxide regulates Nav channel expression. The work utilizes neonatal pig renal vascular preparations and cellular models to investigate how hypoxia/reoxygenation stress activates vascular contraction mechanisms and to identify potential therapeutic targets for preventing ischemic acute kidney injury in newborns. Findings are expected to advance prevention and treatment strategies for kidney diseases, consistent with the NIDDK program's mission to support basic and clinical research improving outcomes for kidney disease patients.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $588.9k | 2/5/26 |